Congenital and hereditary thrombocytopenia purpura
ICD-10 D69.42 is a billable code used to indicate a diagnosis of congenital and hereditary thrombocytopenia purpura.
Congenital and hereditary thrombocytopenia purpura refers to a group of bleeding disorders characterized by a low platelet count (thrombocytopenia) that is present from birth or inherited. This condition can lead to easy bruising, prolonged bleeding from cuts, and spontaneous bleeding episodes. The underlying causes often involve genetic mutations affecting platelet production or function, leading to a reduced number of platelets in circulation. Patients may present with petechiae, purpura, or more severe bleeding complications. Diagnosis typically involves a thorough clinical evaluation, family history assessment, and laboratory tests to measure platelet counts and assess bone marrow function. Management may include platelet transfusions, immunosuppressive therapy, or splenectomy in severe cases. Understanding the genetic basis of the disorder is crucial for family planning and management of affected individuals. The condition can vary in severity, and its impact on quality of life can be significant, necessitating a multidisciplinary approach to care.
Comprehensive patient history, including family history of bleeding disorders, detailed laboratory results, and treatment plans.
Diagnosis and management of patients with unexplained thrombocytopenia, evaluation of bleeding episodes, and genetic counseling.
Ensure accurate documentation of platelet counts and any interventions performed, as well as follow-up care.
Detailed growth and development assessments, family history, and any associated congenital anomalies.
Management of infants and children presenting with bruising or bleeding, and monitoring for complications.
Consider developmental milestones and the impact of the condition on the child's quality of life.
Used to evaluate patients presenting with symptoms of bleeding or bruising.
Document the reason for the CBC and any relevant clinical findings.
Hematologists may require additional tests to assess platelet function.
Congenital thrombocytopenia purpura is primarily caused by genetic mutations that affect platelet production or function, leading to a reduced platelet count from birth.
